Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Drug Delivery Science and Technology"
DOI: 10.1016/j.jddst.2021.102349
Abstract: Abstract Bedaquiline fumarate (BDQN) is approved in year 2012 to treat multidrug resistance tuberculosis (MDR-TB) through accelerated approval pathway by FDA. It belongs to class II of biopharmaceutical classification system (BCS) and shows poor aqueous…
read more here.
Keywords:
bdqn;
dissolution;
solid dispersion;
tsd ... See more keywords